Category

Day: August 1, 2023

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology

Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4-RD Results support the continued development of obexelimab for the treatment of IgG4-RD and potentially other B cell-mediated autoimmune conditions WALTHAM, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to […]

Read More

Conagen and Sumitomo Chemical jointly develop a new era of renewable carbon materials

Bedford, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan’s leading chemical company, have announced to jointly develop p-hydroxystyrene (HS) and its polymer, poly p-hydroxystyrene (PHS), using a combination of biosynthesis, chemosynthesis, and polymerization. The monomer and the polymer are 100% renewable carbon, marking a new era of […]

Read More

Nigeria’s president moves to combat cost of living

Nigeria’s president announced measures to tackle the soaring cost of living on Monday, including the release of 200,000 tonnes of reserve grain after food store looting in the country’s northeast.Since coming to power in May, President Bola Tinubu has…

Read More

Opuwo’s new CEO commences role

Matjandjara Tjihuura Katurota, the newly appointed Chief Executive Officer of Opuwo, began her duties on Tuesday following a special welcoming ceremony at the council chambers.Tjihuura Katurota took over from Petrus Shuuya, who had headed the council …

Read More